Home | Welcome to Contract Pharma   
Last Updated Wednesday, October 22 2014
Print

Breaking News

Related Searches:
May 29, 2014
Revenues up 8% in 2013  Read More »
May 29, 2014
To assess the dosing and performance of a subunit antigen vaccine candidate  Read More »
May 29, 2014
Aims to enhance early phase clinical research in South Korea  Read More »
May 29, 2014
To develop solid dosage manufacturing, packing facility at Manati site  Read More »
May 28, 2014
To pursue OTC approval  Read More »
May 28, 2014
Adds HPAPI processing capabilities at Shanghai lab  Read More »
May 28, 2014
Pretorius to lead clinical research methodologies  Read More »
May 28, 2014
Establishes Anti-Infectives Platform   Read More »
May 28, 2014
Plans to re-introduce U.S. injectable generics products  Read More »
May 23, 2014
To combine ClinPay with clinical technology platform   Read More »
May 23, 2014
Will evaluate data and define the studies to further characterize safety and efficacy  Read More »
May 23, 2014
Gains early- and mid-stage assets in major therapeutic categories  Read More »
May 23, 2014
Despite CHMP opinion, companies will pursue multiple sclerosis indication  Read More »
May 23, 2014
MyTrials aims to increase patient safety, reduce costs  Read More »
May 21, 2014
Rivipansel moves to Phase III development  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On